Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
[1] To demonstrate that the immune responses induced by TIV when administered concomitantly with 13vPnC are noninferior to the immune responses induced by TIV alone [2] To demonstrate that the immune responses to the 13vPnC serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) induced by 13vPnC when administered concomitantly with TIV are noninferior to the immune responses induced by 13vPnC administered 1 month after TIV [3] To evaluate the acceptability of the safety profile of 13vPnC+TIV given concomitantly and 13vPnC given alone
Critère d'inclusion
- Pneumococcal infection